Unknown

Dataset Information

0

Inspiratory muscles do not limit maximal incremental exercise performance in healthy subjects.


ABSTRACT: We investigated whether the inspiratory muscles affect maximal incremental exercise performance using a placebo-controlled, crossover design. Six cyclists each performed six incremental exercise tests. For three trials, subjects exercised with proportional assist ventilation (PAV). For the remaining three trials, subjects underwent sham respiratory muscle unloading (placebo). Inspiratory muscle pressure (P(mus)) was reduced with PAV (-35.9+/-2.3% versus placebo; P<0.05). Furthermore, V(O2) and perceptions of dyspnea and limb discomfort at submaximal exercise intensities were significantly reduced with PAV. Peak power output, however, was not different between placebo and PAV (324+/-4W versus 326+/-4W; P>0.05). Diaphragm fatigue (bilateral phrenic nerve stimulation) did not occur in placebo. In conclusion, substantially unloading the inspiratory muscles did not affect maximal incremental exercise performance. Therefore, our data do not support a role for either inspiratory muscle work or fatigue per se in the limitation of maximal incremental exercise.

SUBMITTER: Romer LM 

PROVIDER: S-EPMC4313890 | biostudies-literature | 2007 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inspiratory muscles do not limit maximal incremental exercise performance in healthy subjects.

Romer Lee M LM   Miller Jordan D JD   Haverkamp Hans C HC   Pegelow David F DF   Dempsey Jerome A JA  

Respiratory physiology & neurobiology 20061110 3


We investigated whether the inspiratory muscles affect maximal incremental exercise performance using a placebo-controlled, crossover design. Six cyclists each performed six incremental exercise tests. For three trials, subjects exercised with proportional assist ventilation (PAV). For the remaining three trials, subjects underwent sham respiratory muscle unloading (placebo). Inspiratory muscle pressure (P(mus)) was reduced with PAV (-35.9+/-2.3% versus placebo; P<0.05). Furthermore, V(O2) and p  ...[more]

Similar Datasets

| S-EPMC7217474 | biostudies-literature
| S-EPMC7419685 | biostudies-literature
| S-EPMC6450328 | biostudies-literature
| S-EPMC9930287 | biostudies-literature
| S-EPMC7161168 | biostudies-literature
| S-EPMC8517227 | biostudies-literature
| S-EPMC7289891 | biostudies-literature
| S-EPMC8297810 | biostudies-literature
| S-EPMC7465505 | biostudies-literature
| S-EPMC10084158 | biostudies-literature